-
Something wrong with this record ?
Rapid and efficient LC-MS/MS diagnosis of inherited metabolic disorders: a semi-automated workflow for analysis of organic acids, acylglycines, and acylcarnitines in urine
B. Piskláková, J. Friedecká, E. Ivanovová, E. Hlídková, V. Bekárek, M. Prídavok, A. Kvasnička, T. Adam, D. Friedecký
Language English Country Germany
Document type Journal Article
- MeSH
- Chromatography, Liquid methods MeSH
- Child MeSH
- Humans MeSH
- Metabolic Diseases * MeSH
- Organic Chemicals MeSH
- Workflow MeSH
- Tandem Mass Spectrometry * methods MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: The analysis of organic acids in urine is an important part of the diagnosis of inherited metabolic disorders (IMDs), for which gas chromatography coupled with mass spectrometry is still predominantly used. METHODS: Ultra-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for urinary organic acids, acylcarnitines and acylglycines was developed and validated. Sample preparation consists only of dilution and the addition of internal standards. Raw data processing is quick and easy using selective scheduled multiple reaction monitoring mode. A robust standardised value calculation as a data transformation together with advanced automatic visualisation tools are applied for easy evaluation of complex data. RESULTS: The developed method covers 146 biomarkers consisting of organic acids (n=99), acylglycines (n=15) and acylcarnitines (n=32) including all clinically important isomeric compounds present. Linearity with r2>0.98 for 118 analytes, inter-day accuracy between 80 and 120 % and imprecision under 15 % for 120 analytes were achieved. Over 2 years, more than 800 urine samples from children tested for IMDs were analysed. The workflow was evaluated on 93 patient samples and ERNDIM External Quality Assurance samples involving a total of 34 different IMDs. CONCLUSIONS: The established LC-MS/MS workflow offers a comprehensive analysis of a wide range of organic acids, acylcarnitines and acylglycines in urine to perform effective, rapid and sensitive semi-automated diagnosis of more than 80 IMDs.
Faculty of Health Care Slovak Medical University Banská Bystrica Slovakia
Faculty of Medicine and Dentistry Palacký University Olomouc Olomouc Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000983
- 003
- CZ-PrNML
- 005
- 20240213093537.0
- 007
- ta
- 008
- 240109s2023 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1515/cclm-2023-0084 $2 doi
- 035 __
- $a (PubMed)37207286
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Piskláková, Barbora $u Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000169620775
- 245 10
- $a Rapid and efficient LC-MS/MS diagnosis of inherited metabolic disorders: a semi-automated workflow for analysis of organic acids, acylglycines, and acylcarnitines in urine / $c B. Piskláková, J. Friedecká, E. Ivanovová, E. Hlídková, V. Bekárek, M. Prídavok, A. Kvasnička, T. Adam, D. Friedecký
- 520 9_
- $a OBJECTIVES: The analysis of organic acids in urine is an important part of the diagnosis of inherited metabolic disorders (IMDs), for which gas chromatography coupled with mass spectrometry is still predominantly used. METHODS: Ultra-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for urinary organic acids, acylcarnitines and acylglycines was developed and validated. Sample preparation consists only of dilution and the addition of internal standards. Raw data processing is quick and easy using selective scheduled multiple reaction monitoring mode. A robust standardised value calculation as a data transformation together with advanced automatic visualisation tools are applied for easy evaluation of complex data. RESULTS: The developed method covers 146 biomarkers consisting of organic acids (n=99), acylglycines (n=15) and acylcarnitines (n=32) including all clinically important isomeric compounds present. Linearity with r2>0.98 for 118 analytes, inter-day accuracy between 80 and 120 % and imprecision under 15 % for 120 analytes were achieved. Over 2 years, more than 800 urine samples from children tested for IMDs were analysed. The workflow was evaluated on 93 patient samples and ERNDIM External Quality Assurance samples involving a total of 34 different IMDs. CONCLUSIONS: The established LC-MS/MS workflow offers a comprehensive analysis of a wide range of organic acids, acylcarnitines and acylglycines in urine to perform effective, rapid and sensitive semi-automated diagnosis of more than 80 IMDs.
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a chromatografie kapalinová $x metody $7 D002853
- 650 12
- $a tandemová hmotnostní spektrometrie $x metody $7 D053719
- 650 _2
- $a průběh práce $7 D057188
- 650 12
- $a metabolické nemoci $7 D008659
- 650 _2
- $a organické látky $7 D009930
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Friedecká, Jaroslava $u Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000180306736
- 700 1_
- $a Ivanovová, Eliška $u Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000306888242
- 700 1_
- $a Hlídková, Eva $u Laboratory for Inherited Metabolic Disorders, Department of Clinical Biochemistry, University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Bekárek, Vojtěch $u Laboratory for Inherited Metabolic Disorders, Department of Clinical Biochemistry, University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Prídavok, Matúš $u Department of Laboratory Medicine, Centre for Inherited Metabolic Disorders, National Institute of Children's Diseases, Bratislava, Slovakia
- 700 1_
- $a Kvasnička, Aleš $u Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic $1 https://orcid.org/000000015973316X
- 700 1_
- $a Adam, Tomáš $u Laboratory for Inherited Metabolic Disorders, Department of Clinical Biochemistry, University Hospital Olomouc, Olomouc, Czech Republic $u Institute of Molecular and Translational Medicine, Czech Advanced Technology and Research Institute (CATRIN), Palacky University Olomouc, Olomouc, Czech Republic $u Faculty of Health Care, Slovak Medical University, Banská Bystrica, Slovakia $1 https://orcid.org/0000000343174708 $7 xx0054162
- 700 1_
- $a Friedecký, David $u Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic $u Laboratory for Inherited Metabolic Disorders, Department of Clinical Biochemistry, University Hospital Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000234489073 $7 xx0142900
- 773 0_
- $w MED00010886 $t Clinical chemistry and laboratory medicine $x 1437-4331 $g Roč. 61, č. 11 (2023), s. 2017-2027
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37207286 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093534 $b ABA008
- 999 __
- $a ok $b bmc $g 2049546 $s 1210677
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 61 $c 11 $d 2017-2027 $e 20230519 $i 1437-4331 $m Clinical chemistry and laboratory medicine $n Clin Chem Lab Med $x MED00010886
- LZP __
- $a Pubmed-20240109